SciELO - Scientific Electronic Library Online

 
vol.30 issue1Profile and safety of metoclopramide use in pediatric patients treated at a second level hospitalWhen to use PUVA or NB-UVB in mycosis fungoides author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


CES Medicina

Print version ISSN 0120-8705

Abstract

CALDERON FLOREZ, Viviana; MACHADO-DUQUE, Manuel E  and  MACHADO-ALBA, Jorge E. Sedation at the end of life. CES Med. [online]. 2016, vol.30, n.1, pp.46-54. ISSN 0120-8705.

Life expectancy has increased; consequently, the incidence of chronic illness has risen. Oncologic patients may present in their final days of life severe symptoms refractory to treatment, such as delirium, dyspnea, psychological stress and existential suffering. Sedation at the end of life is a strategy for the relief of those symptoms, highlighting that the intention is not to shorten life. We describe a pharmacological strategy for end-of-life sedation, along with ethics and legal aspects.

Keywords : Terminal care; Palliative care; Euthanasia; Neoplasm; Deep sedation.

        · abstract in Spanish     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License